Study this credential's subject matter as a set of interpretive filters, not a list of facts. For every drug you review, write one short interpretation paragraph for each context — postmortem, human performance, and antemortem — and force yourself to state the specimen site, the kinetic assumptions, and the limitations in every paragraph. That habit converts the same pharmacology knowledge into defensible casework reasoning.
Pharmacokinetics vs. Toxicokinetics: Same Equations, Different Question
Pharmacokinetics describes drug movement and elimination at ordinary doses; toxicokinetics applies the same parameters when saturation, organ stress, or extreme doses make linear predictions fail. Interpretation at this level asks you to recognize which regime a given case is actually in.
Start with the named contrasts. Under first-order kinetics, a constant fraction of drug clears per unit time, so doubling the dose roughly doubles the concentration but does not change the half-life. Under zero-order kinetics — ethanol at typical drinking levels is the classic example — a constant amount clears per hour, so additional consumption extends elimination time. Saturable (Michaelis-Menten) behavior sits between these regimes, and parameters such as volume of distribution, clearance, and bioavailability only behave predictably when their underlying assumptions hold.
Apply this by interrogating the case before applying any number. Ask whether the exposure was acute or chronic, whether organ function could have changed clearance, and whether the drug is known to shift from first-order toward saturable elimination at toxic concentrations. For a drug with a large volume of distribution, wide tissue uptake means an early blood draw tells you little about total body burden. Write these checks into your notes as a fixed pre-interpretation checklist and run it on every practice case.
Postmortem Redistribution: Why One Blood Value Rarely Speaks for Itself
Postmortem redistribution (PMR) is passive movement of drug from reservoir organs into blood after circulation stops; postmortem diffusion adds movement across tissue boundaries. Concentrations therefore depend heavily on which specimen site was sampled.
The mechanism is concentration-driven diffusion, not active transport. After death, drugs sequestered in liver, lung, or myocardium move down gradients into adjacent blood, which is why heart blood and femoral blood from the same decedent can differ substantially. Highly lipophilic drugs with large volumes of distribution are the ones most frequently discussed in the PMR literature. Decomposition contributes further postmortem diffusion and microbial production of substances such as endogenous ethanol, blurring what an original antemortem level could have been.
Worked scenario: a decedent wears a fentanyl patch, and heart blood drawn at autopsy measures well above antemortem reference values; a colleague concludes a massive overdose from that single number. The better decision is to compare peripheral (femoral) blood, vitreous, and other available specimens, state the postmortem interval, note that fentanyl is among the drugs repeatedly discussed for site-dependent postmortem change, and present a range with stated limitations rather than a point value. It matters because a cause-of-death opinion built on heart blood alone can collapse under cross-examination.
Screening vs. Confirmation: Presumptive Results Are Not Definitive
Screening methods such as immunoassay maximize sensitivity and speed and are presumptive; confirmatory methods such as LC-MS/MS or GC-MS establish compound identity with high specificity. Report language and conclusions must match the method that produced each result.
Learn the vocabulary in both directions. Immunoassay depends on antibody cross-reactivity, so structurally similar compounds can trigger a positive class result — which is exactly what presumptive means. Confirmation rests on retention time plus ion ratios or transitions, an internal standard, matrix-matched calibration, and defined limits of detection and quantification. Validation terms — selectivity, accuracy, precision, carryover, stability, dilution integrity — describe whether each step can be trusted in the specific matrix being tested, whether that is blood, urine, vitreous, or tissue homogenate.
Worked scenario: a decomposed sample screens positive for opiates and the worksheet is annotated as "opiates present." The better decision is to run LC-MS/MS confirmation with matrix-matched controls in decomposed blood, evaluate ion suppression and recovery, and report only the specific analytes confirmed — for instance 6-monoacetylmorphine when it is actually detected. It matters because "the heroin-specific metabolite was confirmed" and "a nonspecific opiate-class signal was observed" support very different investigative conclusions, and decomposition is a recognized source of matrix effects that can suppress or inflate signals.
| Feature | Presumptive screening | Confirmatory testing |
|---|---|---|
| Primary goal | Detect possible presence quickly | Establish compound identity definitively |
| Typical methods | Immunoassay, color spot tests | LC-MS/MS, GC-MS, tandem MS methods |
| Key property | High sensitivity; known cross-reactivity | High specificity; structural evidence |
| Result language | Positive, presumptive, non-confirmed | Confirmed; quantitated where validated |
| Main pitfalls | False positives from cross-reactants | Matrix effects, carryover, weak calibration |
| Interpretation use | Directs the confirmation strategy | Supports conclusions and testimony |
Human Performance Toxicology: Concentration Does Not Equal Impairment
Human performance casework asks whether a substance likely impaired driving or behavior at a specific time. That judgment needs route, dose timing, tolerance, metabolite activity, and observed signs — a concentration compared against a table answers none of these alone.
Contrast this domain with postmortem work. The subject here is alive, so timing questions dominate: when was the drug taken relative to the driving event, and is the parent drug or an active metabolite doing the work? For cannabis, parent THC declines quickly while the active metabolite 11-hydroxy-THC and the inactive carboxy metabolite follow different time courses. For alcohol, back-extrapolation using Widmark-style reasoning depends on elimination-rate assumptions that vary between individuals, which is why those assumptions must be stated rather than silently applied.
Mini scenario: two drivers show the same methamphetamine concentration on a blood draw taken hours after the stop. The tempting shortcut is to declare equivalent impairment. The stronger analysis notes that one subject is a documented chronic user likely to carry substantial tolerance, ties field observations and event times to the concentration, and treats the single value as one data point among several. It matters because human performance conclusions are most defensible when concentration, observed behavior, and pharmacology are reconciled instead of reduced to a threshold number.
Quality Assurance and Legal Aspects: What Makes a Result Survive Court
Quality assurance is the framework — validation, proficiency testing, chain of custody, SOPs, documentation — that lets a result survive challenge. In forensic work the QA record is part of the scientific finding, not administrative overhead.
Anchor your study in the named elements. Method validation establishes that a procedure works in the intended matrix; ongoing proficiency testing shows the analyst still performs it correctly; chain of custody records who handled the specimen and when; standard operating procedures and calibration records make a run reproducible. The ABFT also accredits laboratories practicing postmortem forensic toxicology and human performance toxicology, so laboratory-level standards are worth understanding even though certification addresses the individual scientist.
Mini scenario: a reanalysis request arrives months later and the defense questions whether the retained sample was preserved correctly. The better decision is to pull the custody log, preservation records, and stability data for that analyte in that preservative, and answer with documents rather than reassurance. It matters because stability and custody questions are answerable only when validation and handling records were created prospectively — defensibility cannot be reconstructed after the fact, so practice reading QA files, not just generating numbers from them.
A Context-Switch Drill: Practice One Drug Across Three Case Types
The shared skill across this credential's subject domains is switching interpretive context without mixing assumptions. Run a weekly drill: take one drug and write three short interpretations — postmortem, human performance, antemortem — then score each against a fixed rubric.
Make the drill concrete. In week one, take methadone and write a postmortem paragraph that names specimen sites, PMR potential, and alternative explanations; a human performance paragraph addressing tolerance, timing, and observed signs; and an antemortem paragraph framing a clinical-forensic question such as impaired prescribing. Repeat in later weeks with cocaine, cannabis, and a benzodiazepine. The drug itself is not the point — you are forcing the same kinetic and analytical facts through three different interpretive filters until the switch becomes automatic.
Expected observations: your first rounds will lean too heavily on reference ranges and under-specify limitations; by the third or fourth drug, limitation statements and site selection should appear without prompting. Keep dated versions of every paragraph so the improvement is visible rather than impressionistic. If a paragraph cannot name the analytical method behind each value it cites, that drug's analytical section goes back on the study list before its interpretation notes do.
- Names the specimen, site, and matrix, and states why that site matters for this drug
- States kinetic assumptions explicitly (linear vs. saturable, timing, tolerance)
- Separates presumptive from confirmed results and matches language to method
- Offers at least one alternative explanation and a written limitation statement
- Scoring 4 of 5 consistently is a learning milestone only — not a pass prediction
An Adaptable Eight-Week Sequence and Readiness Checks
Sequence study around interpretation rather than isolated topics: build kinetics and analytical fundamentals first, spend the middle weeks applying them to postmortem, human performance, and QA casework, then close with mixed timed sets.
One adaptable eight-week layout: weeks one and two, kinetics and calculations using clearly labeled practice examples; weeks three and four, analytical methods, validation vocabulary, and the screening-versus-confirmation comparison; week five, postmortem interpretation and PMR; week six, human performance toxicology; week seven, quality assurance, legal aspects, and court-style writing; week eight, mixed case sets under time pressure. Compress or extend to fit your background — the order matters more than the exact week boundaries.
If any readiness check below fails, return to the matching week rather than rereading everything. Administrative details — eligibility, application, scheduling, and continuing education rules — belong to the board rather than to study guides; the ABFT has announced, for example, that CE points for employment activities will be discontinued beginning in 2027 (points claimed in 2028), so confirm current requirements at abft.org before planning any recertification timeline.
- Explain PMR and postmortem diffusion in under a minute without notes
- State, for a set of common drugs, whether PMR is typically discussed and why
- Convert a presumptive result into a confirmation plan, naming the validation checks
- Produce a three-context interpretation with a limitation statement in one sitting
- Score yourself against the section-six rubric; treat the score as a study milestone only
References and further reading
Use these references to explore the concepts and check the latest information from the relevant organizations.